Leave message
Can’t find what you’re looking for?
Fill out this form to inquire about our custom protein services!
Inquire about our Custom Services >>
Expression analysis of human GLP-1R on HEK293/Human GLP-1R Stable Cell Line by FACS.
Cell surface staining using PE-labeled anti-human GLP-1R antibody was performed on HEK293/Human GLP-1R Stable Cell Line with different expression levels: HEK293/Human GLP-1R Stable Cell Line (Low Expression); HEK293/Human GLP-1R Stable Cell Line (Medium Expression); HEK293/Human GLP-1R Stable Cell Line (High Expression).
Expression analysis of human GLP-1R on HEK293/Human GLP-1R Stable Cell Line by FACS.
Cell surface staining using PE-labeled anti-human GLP-1R antibody was performed on HEK293/Human GLP-1R Stable Cell Line with different expression levels: HEK293/Human GLP-1R Stable Cell Line (Low Expression); HEK293/Human GLP-1R Stable Cell Line (Medium Expression); HEK293/Human GLP-1R Stable Cell Line (High Expression).
Dulaglutide captured on Protein A Chip can bind Biotinylated Human GLP1R Full Length Protein, Flag Tag&His,Avitag (Cat. No. GLR-H82D3) with an affinity constant of 1.91 µM as determined in a SPR assay (in presence of DDM and CHS) (Biacore 8K) (Routinely tested).
| Name | Research Code | Research Phase | Company | Indications | Clinical Trials |
|---|---|---|---|---|---|
| NA-931 | NA-931 | Phase 3 Clinical | Biomed Industries Inc | Weight Loss; Diabetes Mellitus, Type 2; Body Weight Changes; Body Weight; Obesity; Overweight; Diabetes Mellitus | Details |
| KAI-4729 | HRS-4729; KAI-4729 | Phase 1 Clinical | Jiangsu Hengrui Medicine Co Ltd | Obesity; Overweight | Details |
| ZT-006 | ZT-006; ZT006 | Phase 1 Clinical | Beijing QL Biopharmaceutical Co Ltd | Diabetes Mellitus, Type 2; Obesity; Diabetes Mellitus; Overweight | Details |
| ANY-002 | ANY-002; ANY002 | Phase 1 Clinical | Anya Biopharm Inc | Details | |
| HM-15275 | HM15275; HM-15275 | Phase 1 Clinical | Hanmi Pharmaceutical Co Ltd | Obesity | Details |
This web search service is supported by Google Inc.
A-Z
